| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
From the Departments of Medicine (J.W.E., J.I.W.) and Biochemistry and Biomedical Sciences (J.I.W.), McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada. * To whom correspondence should be addressed. E-mail: jweitz{at}thrombosis.hhscr.org.
Accepted on ,
A Replacement for Warfarin. The Search Continues
John W. Eikelboom MD and Jeffrey I. Weitz MD*
Key words: Editorials
anticoagulants
thrombosis
This article has been cited by other articles:
![]() |
M. Boodhwani, P. Voisine, M. Ruel, N. R. Sodha, J. Feng, S.-H. Xu, C. Bianchi, and F. W. Sellke Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Janjigian and B. E. Muhs Current Treatment of Acute Lower Extremity Deep Venous Thrombosis International Journal of Lower Extremity Wounds, March 1, 2008; 7(1): 15 - 20. [Abstract] [PDF] |
||||
![]() |
P. Herijgers and P. Verhamme Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for? Eur. Heart J., October 2, 2007; 28(20): 2424 - 2426. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |